Back

My patient has an indication for resynchronisation therapy: conduction system pacing should be first line therapy in all my patients - pro

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: My patient has an indication for device therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Marek Jastrzebski

Jagiellonian University, Krakow (Poland)

3 More presentations in this session

Presentation thumbnail
My patient has an indication for ICD therapy: TV-ICD should be first line therapy in all my patients
Doctor S. Al-Khatib (Durham, US)
Slides Video
Presentation thumbnail
My patient has an indication for ICD therapy: S-ICD should be first line therapy in all my patients
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
My patient has an indication for resynchronisation therapy: conduction system pacing should be first line therapy in all my patients - con
Professor M. Glikson (Jerusalem, IL)
Slides Video

Access the full session

Session thumbnail
My patient has an indication for device therapy
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Session
Great Debates: conduction system pacing - have we found the Holy Grail of physiological pacing?
thumbnail
Congress Presentation
My patient has an indication for resynchronisation therapy: conduction system pacing should be first line therapy in all my patients - con
thumbnail
Congress Presentation
Conduction system pacing should be the first choice for CRT in patients with HFrEF and LBBB

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources